MSD Animal Health announced that the European Commission has granted the marketing authorization for NOBILIS MULTRIVA™ REOm for use in chickens. This vaccine is approved for the active immunization of chickens for the passive immunization of the progeny of the vaccinated chickens to reduce viraemia and clinical signs of disease caused by avian reovirus (ARV) genotypes 1 and 4. Additionally, cross-protection has been established for ARV genotypes 2, 3 and 5.
The primary dose can be administered intramuscularly in the breast or thigh regions as a single dose from 7 weeks of age onwards. As a booster, it should be administered from 8 weeks of age onwards, but no later than 3 weeks before the onset of lay. The vaccine should be given at least 4 weeks after administration of the primary vaccination.
“Ensuring effective prevention and control of avian reovirus is crucial for successful poultry production,” stated Maxim Nakhodko, Global Poultry Business Unit Lead at MSD Animal Health. “The approval of NOBILIS MULTRIVA™ REOm represents a valuable innovation for our customers, offering protection against one of the most significant viral pathogens affecting laying and breeding chickens.”
Simparica Trio Gains FDA Nod to Prevent Flea Tapeworm in Dogs
Zoetis announced that the U.S. Food and Drug Administration (FDA) has approved a new label indication for Simparica Trio to prevent Dipylidium caninum (flea tapeworm) infections by killing Ctenocephalides felis vector fleas in treated dogs. With this approval, Simparica Trio is the only canine combination parasiticide indicated to prevent flea tapeworm infections, at the source, by killing vector fleas before transmission.
“This latest approval of a new indication for Simparica Trio – the second brand label extension in the last six months and the fourth for our parasiticide portfolio – is yet another example of how Zoetis is an industry leader in developing innovative, next-generation parasiticide products and solutions for veterinarians and pet owners,” said Jared Shriver, President, U.S. Operations at Zoetis.
“The best and easiest way to safeguard our pets from parasites is by taking preventative measures to help reduce or eliminate illness,” said Tara Bidgood, DVM, PhD, DACVCP, Vice President, Head of Veterinary Professional Services and Medical Affairs, U.S. Independent Petcare at Zoetis. “Preventing diseases like flea tapeworm infections with this latest FDA approval for Simparica Trio, helps protect our dogs’ health but also helps strengthen the unique bond dogs share with their owners.” said Tara Bidgood
